Physician profile
Smita S Patel
NPI 1043203615
$2,603.44
in general payments reported to CMS, 2019-2025
18 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $213 · 2021: $467 · 2022: $287 · 2023: $516 · 2024: $205 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $929.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $682.68 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $454.67 | 2019-2024 | Xarelto |
| Abbvie INC. | $220.24 | 2019-2024 | |
| Edwards Lifesciences Corporation | $155.56 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Inari Medical, INC. | $149.36 | 2021 | |
| Janssen Scientific Affairs, LLC | $125.00 | 2022 | |
| Stryker Corporation | $125.00 | 2019 | |
| Viatris Specialty LLC | $109.24 | 2025 | Yupelri |
| Novartis Pharmaceuticals Corporation | $101.94 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $99.67 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $97.05 | 2021 | |
| Vifor Pharma, INC. | $86.74 | 2020 | |
| Abbott Laboratories | $71.23 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $36.68 | 2021-2024 | Farxiga |
| Kestra Medical Technology Services, INC. | $31.81 | 2024 | Assure Wcd |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $22.25 | 2023 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $18.68 | 2023 | Verquvo |
| Allergan, INC. | $15.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smita Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.